Submission Details
| 510(k) Number | K151771 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2015 |
| Decision Date | January 05, 2016 |
| Days to Decision | 189 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K151771 is an FDA 510(k) clearance for the Immunalysis Benzodiazepines Urine Enzyme Immunoassay, Immunalysis Multi-Drug Calibrators, a Enzyme Immunoassay, Benzodiazepine (Class II — Special Controls, product code JXM), submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on January 5, 2016, 189 days after receiving the submission on June 30, 2015. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3170.
| 510(k) Number | K151771 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2015 |
| Decision Date | January 05, 2016 |
| Days to Decision | 189 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | JXM — Enzyme Immunoassay, Benzodiazepine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3170 |